159 related articles for article (PubMed ID: 35446717)
1. Risk of malignancy in thyroid nodules with indeterminate (THY3f) cytology.
de Jong MC; McNamara J; Winter L; Roskell D; Khan S; Mihai R
Ann R Coll Surg Engl; 2022 Nov; 104(9):703-709. PubMed ID: 35446717
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
Batawil N; Alkordy T
Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
[TBL] [Abstract][Full Text] [Related]
3. Features and diagnostic accuracy of fine needle aspiration cytology of thyroid nodules: retrospective study from Oman.
Alhassan R; Al Busaidi N; Al Rawahi AH; Al Musalhi H; Al Muqbali A; Shanmugam P; Ramadhan FA
Ann Saudi Med; 2022; 42(4):246-251. PubMed ID: 35933603
[TBL] [Abstract][Full Text] [Related]
4. Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?
Nakamura H; Hirokawa M; Ota H; Kihara M; Miya A; Miyauchi A
Thyroid; 2015 Jul; 25(7):804-11. PubMed ID: 25872408
[TBL] [Abstract][Full Text] [Related]
5. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
6. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
[TBL] [Abstract][Full Text] [Related]
7. Malignancy rates and initial management of Thy3 thyroid nodules in a district general hospital: The 'Reading' experience.
Nair D; Kandiah S; Rourke T; Corbridge R; Nagala S
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00243. PubMed ID: 34277968
[TBL] [Abstract][Full Text] [Related]
8. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
[TBL] [Abstract][Full Text] [Related]
9. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
Goldstein RE; Netterville JL; Burkey B; Johnson JE
Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
[TBL] [Abstract][Full Text] [Related]
10. Fine Needle Aspiration Cytology and Thyroglobulin Antibodies in Preoperative Diagnosis of Thyroid Malignancy.
Hasukic B; Jakubovic-Cickusic A; Sehanovic E; Osmic H
Med Arch; 2019 Dec; 73(6):382-385. PubMed ID: 32082004
[TBL] [Abstract][Full Text] [Related]
11. What really is an indeterminate FNA thyroid nodule?
Pezzolla A; Lattarulo S; Madaro A; Docimo G; Lacalendola E; Prete F; Marzaioli R
Ann Ital Chir; 2017; 88():275-281. PubMed ID: 28632145
[TBL] [Abstract][Full Text] [Related]
12. Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.
Chain K; Legesse T; Heath JE; Staats PN
Cancer Cytopathol; 2019 Aug; 127(8):501-513. PubMed ID: 31150162
[TBL] [Abstract][Full Text] [Related]
13. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
14. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of molecular testing in cytologically indeterminate thyroid nodules with histologic correlation: Experience at a heterogenous multihospital system.
Sura GH; Thrall MJ; Rogers J; Hodjat P; Christensen P; Cubb TD; Khadra HS; Thomas JS; Jacobi EM
Diagn Cytopathol; 2024 Feb; 52(2):82-92. PubMed ID: 37950548
[TBL] [Abstract][Full Text] [Related]
17. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
[TBL] [Abstract][Full Text] [Related]
18. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
[TBL] [Abstract][Full Text] [Related]
20. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
